In active acromegaly, IGF1 bioactivity is related to soluble Klotho levels and quality of life

Research output: Contribution to journalArticleAcademicpeer-review

5 Downloads (Pure)

Abstract

The value of measuring IGF1 bioactivity in active acromegaly is unknown. Soluble Klotho (S-Klotho) level is elevated in active acromegaly and it has been suggested that S-Klotho can inhibit activation of the IGF1 receptor (IGF1R). A cross-sectional study was carried out in 15 patients with active acromegaly based on clinical presentation, unsuppressed GH during an oral glucose tolerance test, and elevated total IGF1 levels (>+2 s.d.). Total IGF1 was measured by immunoassay, IGF1 bioactivity by the IGF1R kinase receptor activation assay and S-Klotho by an ELISA. Quality of Life (QoL) was assessed by Acromegaly QoL (AcroQoL) Questionnaire and Short-Form-36 Health Survey Questionnaire (SF-36). Out of 15 patients, nine had IGF1 bioactivity values within the reference range. S-Klotho was higher in active acromegaly compared with controls. Age-adjusted S-Klotho was significantly related to IGF1 bioactivity (r=0.75, P=0.002) and to total IGF1 (r=0.62, P=0.02). IGF1 bioactivity and total IGF1 were inversely related to the physical component summary of the SF-36 (r=-0.78, P=0.002 vs r=-0.60, P=0.03). Moreover, IGF1 bioactivity, but not total IGF1, was significantly inversely related to the physical dimension of the AcroQoL Questionnaire (r=-0.60, P=0.02 vs r=-0.37, P=0.19). In contrast to total IGF1, IGF1 bioactivity was within the reference range in a considerable number of subjects with active acromegaly. Elevated S-Klotho levels may have reduced IGF1 bioactivity. Moreover, IGF1 bioactivity was more strongly related to physical measures of QoL than total IGF1, suggesting that IGF1 bioactivity may better reflect physical limitations perceived in active acromegaly.

Original languageEnglish
Pages (from-to)85-92
Number of pages8
JournalEndocrine Connections
Volume3
Issue number2
DOIs
Publication statusPublished - 2014

Bibliographical note

Funding:
This work was supported by an unrestricted grant from Novo Nordisk A/S
(Alphen aan de Rijn, The Netherlands). Novo Nordisk A/S had no
involvement in the study design and in the collection, analysis, and
interpretation of data.

Fingerprint

Dive into the research topics of 'In active acromegaly, IGF1 bioactivity is related to soluble Klotho levels and quality of life'. Together they form a unique fingerprint.

Cite this